Glioblastoma Treatment With Irradiation and Olaptesed Pegol (NOX-A12) in MGMT Unmethylated Patients
Clinical trial NCT04121455 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04121455
- Sponsor
- TME Pharma AG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-12
- Primary completion
- 2028-12-01
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.